Eckert & Ziegler: Shares from the capital increase of February 2009 authorised for trading (Prime Standard)

Eckert & Ziegler Strahlen- und Medizintechnik AG / Regulatory Approval
30.09.2009 

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 30.09.2009. The 628.633 shares issued in the course of the rights issue from authorised capital resolved in January 2009 and entered in the Commercial Register on February 6, 2009 were authorised for trading in the regulated market (Prime Standard) of the Frankfurt Stock Exchange with effect from September 30, 2009. The shares will be changed to the common ISIN DE0005659700 effective from October 1, 2009. The notification of the shares will take place also on October 1, 2009.

Eckert & Ziegler AG is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine and has approx. 520 employees. For the current year, the company expects sales of approx. EUR 100 million and earnings per share of approx. EUR 1.80.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de, www.ezag.de




30.09.2009  Financial News transmitted by DGAP

---

 
Language:     English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG               Robert-Rössle-Str.10
              13125 Berlin
              Deutschland
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700, ISIN DE0005659700
WKN:          565970, ISIN DE000A0L1L69
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg  
End of News DGAP News-Service  

---